Genmab A/S (GNMSF)
301.28
-0.69
(-0.23%)
USD |
OTCM |
May 17, 16:00
Genmab Market Cap: 19.46B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 19.46B |
| May 16, 2024 | 19.50B |
| May 15, 2024 | 18.83B |
| May 14, 2024 | 18.59B |
| May 13, 2024 | 18.16B |
| May 10, 2024 | 18.76B |
| May 09, 2024 | 18.37B |
| May 08, 2024 | 17.98B |
| May 07, 2024 | 18.34B |
| May 06, 2024 | 19.16B |
| May 03, 2024 | 18.71B |
| May 02, 2024 | 17.88B |
| May 01, 2024 | 17.64B |
| April 30, 2024 | 17.73B |
| April 29, 2024 | 17.59B |
| April 26, 2024 | 17.74B |
| April 25, 2024 | 17.50B |
| April 24, 2024 | 18.13B |
| April 23, 2024 | 18.83B |
| April 22, 2024 | 18.79B |
| April 19, 2024 | 18.45B |
| April 18, 2024 | 18.87B |
| April 17, 2024 | 18.26B |
| April 16, 2024 | 18.53B |
| April 15, 2024 | 18.33B |
| Date | Value |
|---|---|
| April 12, 2024 | 18.92B |
| April 11, 2024 | 19.40B |
| April 10, 2024 | 19.37B |
| April 09, 2024 | 19.26B |
| April 08, 2024 | 18.99B |
| April 05, 2024 | 19.08B |
| April 04, 2024 | 19.36B |
| April 03, 2024 | 19.03B |
| April 02, 2024 | 19.51B |
| April 01, 2024 | 19.26B |
| March 28, 2024 | 19.97B |
| March 27, 2024 | 19.61B |
| March 26, 2024 | 20.01B |
| March 25, 2024 | 19.66B |
| March 22, 2024 | 19.42B |
| March 21, 2024 | 19.24B |
| March 20, 2024 | 18.91B |
| March 19, 2024 | 19.25B |
| March 18, 2024 | 19.40B |
| March 15, 2024 | 19.68B |
| March 14, 2024 | 19.99B |
| March 13, 2024 | 20.43B |
| March 12, 2024 | 20.33B |
| March 11, 2024 | 20.40B |
| March 08, 2024 | 19.49B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.38B
Minimum
May 30 2019
32.65B
Maximum
Sep 02 2021
21.85B
Average
23.01B
Median
Jan 13 2022
Market Cap Benchmarks
| Ascendis Pharma A/S | 6.918B |
| Galecto Inc | 16.84M |
| Evaxion Biotech AS | 19.40M |
| IO Biotech Inc | 90.92M |
Market Cap Related Metrics
| PE Ratio | 24.97 |
| PS Ratio | 7.675 |
| PEG Ratio | 2.406 |
| Price to Book Value | 4.140 |
| Price to Free Cash Flow | 25.38 |
| Price | 301.28 |
| Earnings Yield | 4.01% |
| PEGY Ratio | 2.406 |
| Operating PE Ratio | 23.98 |
| Normalized PE Ratio | 26.90 |